Eurofins Genomics is globally known for its innovative and customized technologies in the life science industries and academic research. We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression analysis, Sanger sequencing, oligonucleotide, and gene synthesis.
Being passionate about our strong customer orientation, our service and quality standards is our highest priority.
We are an entrepreneurial organization with a dynamic international management team, continuously seeking for new growth opportunities. We encourage our employees to take responsibility and offer personal leeway for shaping the future of the company.
Eurofins is an international life science company that provides clients across a range of industries with a unique range of analytical services to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the world's largest companies to ensure that the products they supply are safe, their ingredients are authentic and the labeling is correct. The company is a leading global provider of analytical services for food, environmental, pharmaceutical and cosmetic products, as well as agricultural contract research organizations (CROs). In addition, Eurofins is one of the independent world market leaders for testing and laboratory services in genomics, pharmacology, forensics, CDMO (contract manufacturing and development), materials science and clinical trial support.
In just 30 years, Eurofins has grown from one laboratory in Nantes, France, to over 58,000 employees in a network of more than 1000 independent companies in over 61 countries with more than 900 laboratories. Eurofins offers a portfolio of more than 200,000 analytical methods to assess the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products as well as innovative clinical diagnostic services as one of the world's leading emerging providers of specialized clinical diagnostic tests.
In 2022, Eurofins generated total revenues of €5.4 billion and has been one of the best performing stocks in Europe over the last 20 years.
Original Stellenanzeige mit Gehaltsinformation auf StepStone.de